<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shariq M</submitter><funding>Department of Biotechnology, Ministry of Science and Technology, India</funding><pagination>636644</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7969667</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Reductive evolution has endowed &lt;i>Mycobacterium tuberculosis&lt;/i> (&lt;i>M. tb&lt;/i>) with moonlighting in protein functions. We demonstrate that RipA (Rv1477), a peptidoglycan hydrolase, activates the NFκB signaling pathway and elicits the production of pro-inflammatory cytokines, TNF-α, IL-6, and IL-12, through the activation of an innate immune-receptor, toll-like receptor (TLR)4. RipA also induces an enhanced expression of macrophage activation markers MHC-II, CD80, and CD86, suggestive of M1 polarization. RipA harbors LC3 (Microtubule-associated protein 1A/1B-light chain 3) motifs known to be involved in autophagy regulation and indeed alters the levels of autophagy markers LC3BII and P62/SQSTM1 (Sequestosome-1), along with an increase in the ratio of P62/Beclin1, a hallmark of autophagy i</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>&lt;i>Mycobacterium tuberculosis&lt;/i> RipA Dampens TLR4-Mediated Host Protective Response Using a Multi-Pronged Approach Involving Autophagy, Apoptosis, Metabolic Repurposing, and Immune Modulation.</pubmed_title><pmcid>PMC7969667</pmcid><funding_grant_id>BT/PR23099/NER/95/632/2017</funding_grant_id><funding_grant_id>BT/PR12817/COE/34/23/2015</funding_grant_id><pubmed_authors>Sharma N</pubmed_authors><pubmed_authors>Sheikh JA</pubmed_authors><pubmed_authors>Singh J</pubmed_authors><pubmed_authors>Ehtesham NZ</pubmed_authors><pubmed_authors>Hasnain SE</pubmed_authors><pubmed_authors>Shariq M</pubmed_authors><pubmed_authors>Quadir N</pubmed_authors><pubmed_authors>Khubaib M</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Mycobacterium tuberculosis&lt;/i> RipA Dampens TLR4-Mediated Host Protective Response Using a Multi-Pronged Approach Involving Autophagy, Apoptosis, Metabolic Repurposing, and Immune Modulation.</name><description>Reductive evolution has endowed &lt;i>Mycobacterium tuberculosis&lt;/i> (&lt;i>M. tb&lt;/i>) with moonlighting in protein functions. We demonstrate that RipA (Rv1477), a peptidoglycan hydrolase, activates the NFκB signaling pathway and elicits the production of pro-inflammatory cytokines, TNF-α, IL-6, and IL-12, through the activation of an innate immune-receptor, toll-like receptor (TLR)4. RipA also induces an enhanced expression of macrophage activation markers MHC-II, CD80, and CD86, suggestive of M1 polarization. RipA harbors LC3 (Microtubule-associated protein 1A/1B-light chain 3) motifs known to be involved in autophagy regulation and indeed alters the levels of autophagy markers LC3BII and P62/SQSTM1 (Sequestosome-1), along with an increase in the ratio of P62/Beclin1, a hallmark of autophagy i</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-07T03:19:44.918Z</modification><creation>2025-04-03T21:33:12.041Z</creation></dates><accession>S-EPMC7969667</accession><cross_references><pubmed>33746976</pubmed><doi>10.3389/fimmu.2021.636644</doi></cross_references></HashMap>